California Reaps $259.7M in Cannabis Tax Revenue for Q2 2025

1.2 min readPublished On: September 16th, 2025By

LOS ANGELES – California’s legal Cannabis sector delivered $259.7 million in tax revenue during the second quarter of 2025, based on data released by the California Department of Tax and Fee Administration (CDTFA). The figure includes $147.3 million from the state’s 15% excise tax on Cannabis products and $112.4 million from sales and use taxes.

This marks a dip from the same period in 2024, when total revenue reached $272.8 million, split between $160.9 million in excise taxes and $111.9 million in sales taxes. The decline reflects broader trends in the industry, with excise collections down by about 8% YOY. For H1 2025, combined revenue hit $502.8 million, incorporating a revised $243.1 million from the first quarter ($142.4 million excise and $100.7 million sales).

The excise tax, which applies at the point of retail sale, funds a range of public initiatives, including childcare services, youth substance abuse prevention, medical research, and environmental restoration efforts tied to past illegal cultivation sites. Since the launch of regulated sales in January 2018, California has amassed more than $7.3 billion in Cannabis-related taxes, with excise contributions totaling $3.9 billion and sales taxes adding $2.9 billion.

A review of quarterly data shows variability in revenue streams:

Quarter

Excise Tax ($M)

Sales Tax ($M)

Total ($M)

Q2 2025

147.3 112.4 259.7

Q1 2025

142.4

100.7

243.1

Q2 2024

160.9

111.9

272.8

Q1 2024 159.7 109.4

269.1

Peak (Q2 2021) N/A N/A

361.4

These numbers highlight a stabilization below the high-water mark set in 2021, following the elimination of the cultivation tax in mid-2022, which aimed to reduce costs for growers and retailers. While quarterly totals have not returned to those levels, the consistent flow of funds demonstrates the sector’s enduring fiscal impact.

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!